EC Number |
Disease |
PubMed ID |
Title of Publication |
Category |
Confidence Level |
---|
3.1.4.37 | 2',3'-cyclic-nucleotide 3'-phosphodiesterase deficiency |
22155618 |
Adult CNP::EGFP transgenic mouse shows pronounced hypomyelination and an increased vulnerability to cuprizone-induced demyelination. |
causal interaction unassigned |
4 0 |
3.1.4.37 | 2',3'-cyclic-nucleotide 3'-phosphodiesterase deficiency |
26721674 |
Discovery and Roles of 2',3'-cAMP in Biological Systems. |
causal interaction unassigned |
3 0 |
3.1.4.37 | Acute Kidney Injury |
26721674 |
Discovery and Roles of 2',3'-cAMP in Biological Systems. |
causal interaction unassigned |
3 0 |
3.1.4.37 | Adenomatous Polyposis Coli |
15878785 |
Suppression of glial activation is involved in the protection of IL-10 on maternal E. coli induced neonatal white matter injury. |
causal interaction therapeutic application unassigned |
1 4 0 |
3.1.4.37 | Adenomatous Polyposis Coli |
33404293 |
BNIP3L-mediated mitophagy is required for mitochondrial remodeling during the differentiation of optic nerve oligodendrocytes. |
ongoing research unassigned |
1 0 |
3.1.4.37 | Adrenal Gland Neoplasms |
23242804 |
Histologic and Immunohistochemical Classification of 41 Bovine Adrenal Gland Neoplasms. |
causal interaction diagnostic usage ongoing research therapeutic application |
4 2 3 2 |
3.1.4.37 | Alzheimer Disease |
2555748 |
2',3'-cyclic nucleotide-3'-phosphodiesterase activity as an index of myelin in the post-mortem brains of patients with Alzheimer's disease. |
causal interaction diagnostic usage unassigned |
3 4 0 |
3.1.4.37 | Alzheimer Disease |
11445254 |
Decreased brain levels of 2',3'-cyclic nucleotide-3'-phosphodiesterase in Down syndrome and Alzheimer's disease. |
causal interaction diagnostic usage unassigned |
3 3 0 |
3.1.4.37 | Alzheimer Disease |
19473295 |
Abundant extracellular myelin in the meninges of patients with multiple sclerosis. |
diagnostic usage ongoing research unassigned |
1 3 0 |
3.1.4.37 | Bell Palsy |
1338291 |
Virus-associated demyelination in the pathogenesis of Bell's palsy. |
diagnostic usage ongoing research unassigned |
2 2 0 |